Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes

0Shares

RELATED PRODUCTS
  • Essentials you need along with Free Topic Ideas for your Women's Group
  • Discover how to create a fun, profitable and effective mastermind group faster and easier.
  • My Piano Dream Is The Best Piano Solos For Everyone On The Hao Staff.
  • Read a chapter a day from the bible's book of the revelation or hebrews.
  • How to make your own adult board games for couples. Include stripping and foreplay.
  • The easy to understand math tutorials Collection
  • This program can achieve a lean sculpted attractive body that you desire without diet or gym.
  • Includes all the prepping tips, tricks, tactics and techniques you could possibly need.
  • Discover The 12 Amazing Holiday Classics That You Can Play with Just 3 Easy Guitar Chords
  • A membership web site and job board that caters to people looking for legitimate home-based jobs
  • Ads by MyCBGenie 
     

    Dietary treatment is important in management of type 2 diabetes or prediabetes, but uncertainty exists about the optimal diet. We randomized adults (n = 34) with glycated hemoglobin (HbA1c) > 6.0% and elevated body weight (BMI > 25) to a very low-carbohydrate ketogenic (LCK) diet (n = 16) or a moderate-carbohydrate, calorie-restricted, low-fat (MCCR) diet (n = 18). All participants were encouraged to be physically active, get sufficient sleep, and practice behavioral adherence strategies based on positive affect and mindful eating. At 12 months, participants in the LCK group had greater reductions in HbA1c levels (estimated marginal mean (EMM) at baseline = 6.6%, at 12 mos = 6.1%) than participants in MCCR group (EMM at baseline = 6.9%, at 12 mos = 6.7%), p = .007. Participants in the LCK group lost more weight (EMM at baseline = 99.9 kg, at 12 mos = 92.0 kg) than participants in the MCCR group (EMM at baseline = 97.5 kg, at 12 mos = 95.8 kg), p < .001. The LCK participants experienced larger reductions in diabetes-related medication use; of participants who took sulfonylureas or dipeptidyl peptidase-4 inhibitors at baseline, 6/10 in the LCK group discontinued these medications compared with 0/6 in the MCCR group (p = .005). In a 12-month trial, adults with elevated HbA1c and body weight assigned to an LCK diet had greater reductions in HbA1c, lost more weight, and reduced more medications than those instructed to follow an MCCR diet.

    Source

     

    Loading ....
    0Shares

    Related posts

    Leave a Comment